Medline has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) related to a proposed public offering of its common stock.

Medline seeks IPO 50B valuation by filing for a $5 billion offering led by Goldman Sachs and Morgan Stanley on Nasdaq.

Strategy announced its intention to conduct an IPO of 3,500,000 shares of Strategy’s Series A STRE Stock, with plans to ...

Infleqtion, a quantum computing company and Nvidia ($NVDA) partner, is inching closer to its IPO expected in late 2025 or ...

The Palo Alto company, which targets millennial and Gen Z investors, would follow recent listings from Chime, Circle, eToro, ...

Acushnet, parent company of golf industry leading brands Titleist and FootJoy, generated more than $1.5 billion in net sales in 2015. Soon, you can own a piece of it. But before you do, make sure you ...

M2 Compliance, LLC ("M2 Compliance"), a leading full-service SEC filing and financial-disclosure agency providing complete solutions for EDGAR, iXBRL, proxy, and financial-printing requirements, today ...

IPO-bound OYO's parent firm PRISM has initiated a fresh round of corporate actions, including an increase in its authorised ...

The Oracle of Omaha has jettisoned over 427 million shares of Bank of America since July 2024, but has built up Berkshire's position in a business with well-defined competitive edges for four ...

SBI Optimal Equity Fund and SBI Emergent Fund have invested ₹100 crore in Lenskart Solutions ahead of its IPO at ₹402 per ...

It must be noted that Neha Bansal had already reduced her OFS before the IPO, having sold Rs 90 crore worth of shares to ...